Norquetiapine

Details

Stereochemistry	ACHIRAL
Molecular Formula	C17H17N3S
Molecular Weight	295.402
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C1CN(CCN1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3

InChI

InChIKey=JLOAJISUHPIQOX-UHFFFAOYSA-N

InChI=1S/C17H17N3S/c1-3-7-15-13(5-1)17(20-11-9-18-10-12-20)19-14-6-2-4-8-16(14)21-15/h1-8,18H,9-12H2

HIDE SMILES / InChI

Molecular Formula	C17H17N3S
Molecular Weight	295.402
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:07:57 GMT 2025` Edited by `admin` on `Mon Mar 31 18:07:57 GMT 2025`
Record UNII	V3H1ZVV9S6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Norquetiapine

Common Name

English

N-DESALKYLQUETIAPINE

Preferred Name

English

QUETIAPINE FUMARATE IMPURITY B [EP IMPURITY]

Common Name

English

Code System Code Type Description

PUBCHEM

11369918

Created by admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025

PRIMARY

EPA CompTox

DTXSID30881147

Created by admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025

PRIMARY

FDA UNII

V3H1ZVV9S6

Created by admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025

PRIMARY

CAS

5747-48-8

Created by admin on Mon Mar 31 18:07:57 GMT 2025 , Edited by admin on Mon Mar 31 18:07:57 GMT 2025

PRIMARY

Related Record Type Details


					7VJ4TC63IL

Norquetiapine dihydrochloride

SALT/SOLVATE -> PARENT

Amount:


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE

Amount:


					8E4LAA4357

CYTOCHROME P450 2D6

METABOLIC ENZYME -> SUBSTRATE

Amount:


					Q7A4S7HOP4

ALPHA-1B ADRENERGIC RECEPTOR

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					28XBT591QG

HISTAMINE H1 RECEPTOR

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					NQI5D806LC

5-HYDROXYTRYPTAMINE RECEPTOR 2A

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					54202V7DRJ

D(1A) DOPAMINE RECEPTOR

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					UKK18ES9TF

5-HYDROXYTRYPTAMINE RECEPTOR 1A

TARGET->PARTIAL AGONIST

Qualification:

Ki

Amount:


					V23K99CV7G

MUSCARINIC ACETYLCHOLINE RECEPTOR M1

TARGET -> INHIBITOR

Qualification:

Ki

Amount:


					HN86OLH1NW

SODIUM-DEPENDENT NORADRENALINE TRANSPORTER

TARGET -> INHIBITOR

Qualification:

Ki

Amount:

Related Record Type Details


					NB6I4M7RFP

7-HYDROXY-N-DESALKYLQUETIAPINE

METABOLITE ACTIVE -> PARENT

Amount:


					BGL0JSY5SI

QUETIAPINE

PARENT -> METABOLITE ACTIVE

Interaction Type:

MAJOR

Amount:


					BIJ1Q409UA

11-(1-PIPERAZINYL)DIBENZO(B,F)(1,4)THIAZEPINE 5-OXIDE

METABOLITE -> PARENT

Amount:

Related Record Type Details


					2S3PL1B6UJ

Quetiapine Fumarate

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC				Half-life PHARMACOKINETIC